⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IOBT News
IO Biotech, Inc. Common Stock
Cancer Immunotherapy Research Report 2026: Market Forecasts 2025-2029 for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer with Executive and Consultant Guides
globenewswire.com
ABBV
ADAG
ADAP
ACET
ALXO
AMBR
AMGN
RCUS
AZN
ATRC
BBLU
BIIB
BNTX
BOLT
BMY
CRBU
CLDX
CRVS
LLY
EVAX
GNSS
GILD
GLSI
IMUX
IMMX
IMNM
INCY
INDP
ISRL
IOBT
JNJ
MRK
MRNA
MBIO
NVS
NVX
PDSB
PFE
REGN
SNY
SNT
URGN
ZYME
IO Biotech Provides Corporate Update
globenewswire.com
IOBT
IO Biotech Announces Exploration of Strategic Alternatives
globenewswire.com
IOBT
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
globenewswire.com
CAH
JNJ
PFE
IQV
IOBT
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
globenewswire.com
IOBT
IO Biotech Announces Participation in Upcoming December Investor Conferences
globenewswire.com
IOBT
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
globenewswire.com
IOBT
IO Biotech Announces Participation in Upcoming Investor Conferences
globenewswire.com
IOBT
IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
globenewswire.com
IOBT
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
prnewswire.com
IOBT
NVS
BCAX
PFE